Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
American Journal of Human Genetics|March 15, 2006
The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translationAnne Puel, Janine Reichenbach, Jacinta Bustamante, et al.Oncotarget|December 2, 2016
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemiaValentina Griggio, Giorgia Mandili, Candida Vitale, et al.Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.Gut|November 12, 2018
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancerDelphine Goehrig, Jérémy Nigri, Rémi Samain, et al.Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.Clinical Science (London, England : 1979)|November 22, 2015
Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancerElena Niccolai, Antonio Taddei, Federica Ricci, et al.Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.Journal of Proteome Research|May 12, 2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancerBarbara Tomaino, Paola Cappello, Michela Capello, et al.The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.Pageof 11